Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rxsight Inc RXST

Healthcare Medical Devices
RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL... see more

Recent & Breaking News (NDAQ:RXST)

RxSight, Inc. Reports Third Quarter 2024 Financial Results

GlobeNewswire November 7, 2024

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

GlobeNewswire October 24, 2024

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

GlobeNewswire August 22, 2024

RxSight, Inc. Reports Second Quarter 2024 Financial Results

GlobeNewswire August 5, 2024

RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024

GlobeNewswire July 22, 2024

RxSight, Inc. To Participate in the Truist Securities Medtech Conference

GlobeNewswire June 5, 2024

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

GlobeNewswire May 30, 2024

RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewswire May 13, 2024

RxSight, Inc. Announces Pricing of Public Offering of Common Stock

GlobeNewswire May 8, 2024

RxSight, Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire May 8, 2024

RxSight, Inc. Reports First Quarter 2024 Financial Results

GlobeNewswire May 6, 2024

RxSight, Inc. to Present at the Bank of America Healthcare Conference

GlobeNewswire May 1, 2024

RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024

GlobeNewswire April 22, 2024

RxSight Announces Commercial Launch of its Newest Light Adjustable Lens(TM), the LAL+(TM), and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting

GlobeNewswire April 4, 2024

RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire March 27, 2024

RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference

GlobeNewswire February 29, 2024

RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire February 28, 2024

RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 

GlobeNewswire February 14, 2024

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance

GlobeNewswire January 7, 2024

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

GlobeNewswire December 27, 2023